These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 28170403)
1. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients. Cox MJ; Turek EM; Hennessy C; Mirza GK; James PL; Coleman M; Jones A; Wilson R; Bilton D; Cookson WO; Moffatt MF; Loebinger MR PLoS One; 2017; 12(2):e0170622. PubMed ID: 28170403 [TBL] [Abstract][Full Text] [Related]
2. A novel microbiota stratification system predicts future exacerbations in bronchiectasis. Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925 [TBL] [Abstract][Full Text] [Related]
3. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study. Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805 [TBL] [Abstract][Full Text] [Related]
4. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial. Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200 [TBL] [Abstract][Full Text] [Related]
5. Dynamic Upper and Lower Airway Microbiotas in Paediatric Bronchiectasis Exacerbations: A Pilot Study. Broderick DTJ; Regtien T; Ainsworth A; Taylor MW; Pillarisetti N Front Cell Infect Microbiol; 2021; 11():773496. PubMed ID: 35141165 [TBL] [Abstract][Full Text] [Related]
6. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis. Byun MK; Chang J; Kim HJ; Jeong SH PLoS One; 2017; 12(8):e0183553. PubMed ID: 28829833 [TBL] [Abstract][Full Text] [Related]
7. The metabolic footprint of the airway bacterial community in cystic fibrosis. Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467 [TBL] [Abstract][Full Text] [Related]
8. The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Ho PL; Chan KN; Ip MS; Lam WK; Ho CS; Yuen KY; Tsang KW Chest; 1998 Dec; 114(6):1594-8. PubMed ID: 9872194 [TBL] [Abstract][Full Text] [Related]
9. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400 [TBL] [Abstract][Full Text] [Related]
11. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)]. ; ; Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700 [TBL] [Abstract][Full Text] [Related]
12. Impact of prophylactic and 'rescue pack' antibiotics on the airway microbiome in chronic lung disease. Rofael SAD; Brown J; Lipman MCI; Lowe DM; Spratt D; Quaderi S; Hurst JR; McHugh TD BMJ Open Respir Res; 2023 Apr; 10(1):. PubMed ID: 37085283 [TBL] [Abstract][Full Text] [Related]
13. Composition of airway bacterial community correlates with chest HRCT in adults with bronchiectasis. O'Neill K; Einarsson GG; Rowan S; McIlreavey L; Lee AJ; Lawson J; Lynch T; Horsley A; Bradley JM; Elborn JS; Tunney MM Respirology; 2020 Jan; 25(1):64-70. PubMed ID: 31364220 [TBL] [Abstract][Full Text] [Related]
15. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations. Huang YJ; Boushey HA Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis. Taylor SL; Rogers GB; Chen AC; Burr LD; McGuckin MA; Serisier DJ Ann Am Thorac Soc; 2015 May; 12(5):701-7. PubMed ID: 25679336 [TBL] [Abstract][Full Text] [Related]
17. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum. Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714 [TBL] [Abstract][Full Text] [Related]
18. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity]. Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282 [No Abstract] [Full Text] [Related]
19. The lung microbiome in children with HIV-bronchiectasis: a cross-sectional pilot study. Masekela R; Vosloo S; Venter SN; de Beer WZ; Green RJ BMC Pulm Med; 2018 May; 18(1):87. PubMed ID: 29788934 [TBL] [Abstract][Full Text] [Related]
20. Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients. Dimakou K; Triantafillidou C; Toumbis M; Tsikritsaki K; Malagari K; Bakakos P Respir Med; 2016 Jul; 116():1-7. PubMed ID: 27296814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]